Judith S. Sebolt–Leopold
Biochemistry, Genetics and Molecular Biology · University of Michigan
Publications
209
Citations
9,578
Est. group size
~15
Recurring co-author estimate
Active years
35
Publishing since 1991
Typically publishes in teams of ~7 · 5% small-team papers (≤3 authors) · across 11 venues
- Supplementary Dataset Legends from Loss of NF1 in Melanoma Confers Sensitivity to SYK Kinase Inhibition
2025
- Abstract 5603: A precision polypharmacology approach to co-target EGFR and PI3 kinase: the power of structure-based drug design to generate therapeutic agents with versatility in multiple combination settings
Cancer Research · 2025
- Supplementary Dataset S5 from Loss of NF1 in Melanoma Confers Sensitivity to SYK Kinase Inhibition
2025
- Supplementary Dataset S3 from Loss of NF1 in Melanoma Confers Sensitivity to SYK Kinase Inhibition
2025
- Supplementary Dataset S1 from Loss of NF1 in Melanoma Confers Sensitivity to SYK Kinase Inhibition
2025
- Supplementary Figures from Loss of NF1 in Melanoma Confers Sensitivity to SYK Kinase Inhibition
2025
- Supplementary Dataset S9 from Loss of NF1 in Melanoma Confers Sensitivity to SYK Kinase Inhibition
2025
- Supplementary Dataset S4 from Loss of NF1 in Melanoma Confers Sensitivity to SYK Kinase Inhibition
2025
- Supplementary Dataset S8 from Loss of NF1 in Melanoma Confers Sensitivity to SYK Kinase Inhibition
2025
- Supplementary Dataset S2 from Loss of NF1 in Melanoma Confers Sensitivity to SYK Kinase Inhibition
2025
- Supplementary Dataset S6 from Loss of NF1 in Melanoma Confers Sensitivity to SYK Kinase Inhibition
2025
- Supplementary Dataset S7 from Loss of NF1 in Melanoma Confers Sensitivity to SYK Kinase Inhibition
2025
- A first-in-class selective inhibitor of EGFR and PI3K offers a single-molecule approach to targeting adaptive resistance
Nature Cancer · 2024
- Abstract 1230: MTX-531, a first-in-class pan-PI3K inhibitor spares hyperinsulinemia yielding durable tumor regressions and resilience to adaptive resistance
Cancer Research · 2024
- Data from Loss of NF1 in Melanoma Confers Sensitivity to SYK Kinase Inhibition
2024
- Cancer Research×11
- Molecular Cancer Therapeutics×3
- Neuro-Oncology×3
- Nature Communications×1
- Nature Cancer×1
- Elizabeth K. Ziemke
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Samantha Steele
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Christopher E. Whitehead
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Christy L. Frankowski-McGregor
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Eric J. Lachacz
Biochemistry, Genetics and Molecular Biology · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile